This study is for the treatment of stage III non-small cell lung cancer
Primary disease category: Cancer
Secondary disease categories: Cancer, Lung Cancer
Sponsor: Southwest Oncology Group
Protocol number: S1206
Projected enrollment dates: October 2013 to December 2016
Official study title: S1206: A Dose Finding Study Followed by Phase II Randomized, Placebo-Controlled Study of Veliparib (ABT-888) Added to Chemoradiotherapy with Carboplatin and Paclitaxel for Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC), (NCI Study Number 8811)
ClinicalTrials.gov page:
http://www.clinicaltrials.gov/show/NCT01386385